Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with non-adherence to HAART

International Journal of STD and AIDS

Volumn 15, Issue 1, 2004, Pages 38-44

  Horne, Robert ^a   Buick, Deanna ^a   Fisher, Martin ^b   Leake, Heather ^b   Cooper, Vanessa ^a   Weinman, John ^c  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b BRIGHTON GENERAL HOSPITAL   (United Kingdom)

^c Psychology Unit   (United Kingdom)

Author keywords

Adherence; Antiretroviral therapy; HIV AIDS; Patient beliefs

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN;

AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADULT; AMBULATORY CARE FACILITIES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HIV INFECTIONS; HUMANS; MALE; QUESTIONNAIRES; TREATMENT REFUSAL;

EID: 0347302928     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646204322637245     Document Type: Article

References (27)

1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2001;133:21-30
2. Proctor V, Tesfa A, Tompkins D. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with AIDS/HIV. AIDS Patient Care STDs 1999;13:535-44
3. Catt S, Stygall J, Catalan J. Acceptance of zidovudine (AZT) in early HIV disease: the role of health beliefs. AIDS Care 1995;7:229-35
4. Ezzy DM, Bartos MR, de Visser RO, Rosenthal DA. Antiretroviral uptake in Australia: medical, attitudinal and cultural correlates. Int J STD AIDS 1998;9:579-86
5. Aversa S, Kimberlin C. Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Educ Couns 1996;29:207-19
6. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med 2000;50:1599-605
7. Mehta S, Moore RD, Graham NMH. Potential factors affecting adherence with HIV. AIDS 1997;11:1665-70
8. Siegel K, Gorey E. HIV infected women: Barriers to AZT use. Soc Sci Med 1997;45:15-22
9. Smith M, Rapkin B, Morrison A, Kammerman S. Zidovudine adherence in persons with AIDS. J Gen Intern Med 1997;12:216-23
10. Nannis E, Temoshok L, Smith M, Jenkins R. Perceptions of AZT: Implications for adherence to medical regimens. J App Biobehav Res 1993;1:39-54
11. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire (BMQ): the development and evaluation of a new method for assessing cognitive representations of medication. Psychol Health 1999;14:1-24
12. Horne R. Patients beliefs about treatment: the hidden determinant of treatment outcome? J Psychsom Res 1999;47:491-5
13. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555-67
14. Walsh JC, Dalton M, Gazzard BG. Adherence to combination antiretroviral therapy assessed by anonymous patient self-report. AIDS 2000;12:2361-3
15. Oppenheim AN. Questionnaire design, interviewing and attitude measurement. London: Pinter, 1992
16. Tabachnick BG, Fidell LS. Using multivariate statistics. New York: Harper Collins, 1989
17. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985;20:29-37
18. Morgan M, Watkins CJ. Managing hypertension: beliefs and responses to medication among cultural groups. Social Health III 1988;10:561-78
19. Carr A, Samaras K, Thorlsdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 2001;353:2093-9
20. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholtz CD, Mukherjee J. Can simple clinical measures detect patient non-compliance? Hypertension 1980;2:757-64
21. Morisky DE, Green LW, Levine DM. Concurrent predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74
22. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999;13:1099-107
23. Rand CS, Wise RA. Measuring adherence to asthma medications. Am J Respir Crit Care Med 1994;149:s69-76
24. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised clinical trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383-6
25. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002;17:17-32
26. Webb DG, Horne R, Pinching AJ. Treatment-related empowerment: preliminary evaluation of a new measure in patients with advanced HIV disease. Int J STD AIDS 2001;12:103-7
27. Marinker M. Personal paper: writing prescriptions is easy. BMJ 1997;314:747-8